Yedavalli Vivek, Salim Hamza Adel, Musmar Basel, Adeeb Nimer, El Naamani Kareem, Henninger Nils, Sundararajan Sri Hari, Kühn Anna Luisa, Khalife Jane, Ghozy Sherief, Scarcia Luca, Tan Benjamin Yq, Regenhardt Robert W, Heit Jeremy J, Cancelliere Nicole M, Bernstock Joshua D, Rouchaud Aymeric, Fiehler Jens, Sheth Sunil, Puri Ajit S, Dyzmann Christian, Colasurdo Marco, Barreau Xavier, Renieri Leonardo, Filipe João Pedro, Harker Pablo, Radu Răzvan Alexandru, Abdalkader Mohamad, Klein Piers, Marotta Thomas R, Spears Julian, Ota Takahiro, Mowla Ashkan, Jabbour Pascal, Biswas Arundhati, Clarençon Frédéric, Siegler James E, Nguyen Thanh N, Varela Ricardo, Baker Amanda, Essibayi Muhammed Amir, Altschul David, Gonzalez Nestor R, Möhlenbruch Markus A, Costalat Vincent, Gory Benjamin, Stracke Christian Paul, Aziz-Sultan Mohammad Ali, Hecker Constantin, Shaikh Hamza, Liebeskind David S, Pedicelli Alessandro, Alexandre Andrea M, Tancredi Illario, Faizy Tobias D, Kalsoum Erwah, Lubicz Boris, Patel Aman B, Pereira Vitor Mendes, Guenego Adrien, Dmytriw Adam A
Department of Radiology, Division of Neuroradiology, Johns Hopkins Medical Center, Baltimore, MD, USA.
Neuroendovascular Program, Massachusetts General Hospital & Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Eur Stroke J. 2024 Sep 13:23969873241275531. doi: 10.1177/23969873241275531.
Medium vessel occlusion (MeVO) strokes, particularly affecting the M2 segment of the middle cerebral artery, represent a critical proportion of acute ischemic strokes, posing significant challenges in management and outcome prediction. The efficacy of mechanical thrombectomy (MT) in MeVO stroke may warrant reliable predictors of functional outcomes. This study aimed to investigate the prognostic value of follow-up infarct volume (FIV) for predicting 90-day functional outcomes in MeVO stroke patients undergoing MT.
This multicenter, retrospective cohort study analyzed data from the Multicenter Analysis of primary Distal medium vessel occlusions: effect of Mechanical Thrombectomy (MAD-MT) registry, covering patients with acute ischemic stroke due to M2 segment occlusion treated with MT. We examined the relationship between 90-day functional outcomes, measured by the modified Rankin Scale (mRS), and follow-up infarct volume (FIV), assessed through CT or MRI within 12-36 h post-MT.
Among 130 participants, specific FIV thresholds were identified with high specificity and sensitivity for predicting outcomes. A FIV ⩽5 ml was highly specific for predicting favorable and excellent outcomes. The optimal cut-off for both prognostications was identified at ⩽15 ml by the Youden Index, with significant reductions in the likelihood of favorable outcomes observed above a 40 ml threshold. Receiver Operator Curve (ROC) analyses confirmed FIV as a superior predictor of functional outcomes compared to traditional recanalization scores, such as final modified thrombolysis in cerebral infarction score (mTICI). Multivariable analysis further highlighted the inverse relationship between FIV and positive functional outcomes.
FIV within 36 h post-MT serves as a potent predictor of 90-day functional outcomes in patients with M2 segment MeVO strokes. Establishing FIV thresholds may aid in the prognostication of stroke outcomes, suggesting a role for FIV in guiding post intervention treatment decisions and informing clinical practice. Future research should focus on validating these findings across diverse patient populations and exploring the integration of FIV measurements with other clinical and imaging markers to enhance outcome prediction accuracy.
中型血管闭塞(MeVO)性卒中,尤其是累及大脑中动脉M2段的卒中,在急性缺血性卒中中占相当比例,给治疗和预后预测带来重大挑战。机械取栓术(MT)治疗MeVO性卒中的疗效可能需要可靠的功能预后预测指标。本研究旨在探讨随访梗死体积(FIV)对接受MT治疗的MeVO性卒中患者90天功能预后的预测价值。
这项多中心回顾性队列研究分析了来自原发性远端中型血管闭塞多中心分析:机械取栓术(MAD-MT)登记处的数据,涵盖因M2段闭塞接受MT治疗的急性缺血性卒中患者。我们通过改良Rankin量表(mRS)测量90天功能预后与MT后12 - 36小时内通过CT或MRI评估的随访梗死体积(FIV)之间的关系。
在130名参与者中,确定了具有高特异性和敏感性的特定FIV阈值用于预测预后。FIV≤5 ml对预测良好和优异预后具有高度特异性。通过约登指数确定两种预后的最佳截断值为≤15 ml,在40 ml阈值以上观察到良好预后的可能性显著降低。受试者工作特征曲线(ROC)分析证实,与传统再通评分(如最终脑梗死改良溶栓评分[mTICI])相比,FIV是功能预后的更优预测指标。多变量分析进一步强调了FIV与积极功能预后之间的负相关关系。
MT后36小时内的FIV可作为M2段MeVO性卒中患者90天功能预后的有力预测指标。确定FIV阈值可能有助于卒中预后的预测,表明FIV在指导干预后治疗决策和为临床实践提供信息方面的作用。未来的研究应专注于在不同患者群体中验证这些发现,并探索将FIV测量与其他临床和影像学标志物相结合以提高预后预测准确性。